Drugmakers go under the skin, skirting early US Medicare price negotiations

By Michael Erman NEW YORK (Reuters) – Injectable versions of some widely-used cancer drugs including Johnson & Johnson’s blockbuster multiple myeloma treatment Darzalex are likely to be excluded from new U.S. government price negotiations for years, drugmakers told Reuters, protecting billions in revenue. Whether the government agrees that adding an ingredient enabling infused drugs to…

Read More

Brazil set to kick off monetary easing with small rate cut on Aug 2: Reuters poll

By Luana Maria Benedito and Marcela Ayres SAO PAULO (Reuters) – Brazil’s central bank is poised for its first interest rate cut in three years on Wednesday, with most economists anticipating a small reduction despite government calls for more aggressive action as inflation cools and economic activity loses steam. After pushing the benchmark rate 1,175…

Read More